Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Analysis of Outcomes for Drivers with Epilepsy in MD

Epilepsia; ePub 2017 Jun 1; Ma, Bloch, et al

Maryland's individualized system for assessing driving applicants with epileptic seizures resulted in a dynamic process of approvals and denials based on favorable and unfavorable risk factors and lengths of seizure freedom, a recent retrospective study found. Maryland updated its driving regulation guidelines in 2003 to reflect those of a US consensus guideline requiring a minimum 3-month seizure-free period as well as an individual risk assessment by a Medical Advisory Board (MAB). MAB reviews and licensing records for Maryland driver applicants with seizures between 2004 and 2005 were reviewed, during which 254 first-time applicants were processed. Researchers found:

  • The MAB approved driving for 74.8% of initial applicants; most had been seizure-free for over 6 months.
  • Approved drivers had a longer median seizure-free period (563 days) compared to those who were denied (104.5 days), and 22.7% of approved drivers had seizures recur during monitoring over the next year, although none resulted in crashes or deaths.
  • Of applicants initially denied (n=50), 89.3% were eventually licensed.
  • Treating physicians recommended driving for 84.4% of applicants rejected by the MAB.
Citation:

Ma BB, Bloch J, Krumholz, et al. Regulating drivers with epilepsy in Maryland: Results of the application of a United States consensus guideline. [Published online ahead of print June 1, 2017]. Epilepsia. doi:10.1111/epi.13804.

This Week's Must Reads

Cognitive Decline and Tauopathy Examined, JAMA Neurol; ePub 2017 Oct 2; Buckley, et al

Hippocampal Atrophy and Post-Mortem TDP-43 in AD, Lancet Neurol; ePub 2017 Sep 11; Josephs, et al

Early-Onset Hypertension in Women & Dementia Risk, Neurology; ePub 2017 Oct 4; Gilsanz, Mayeda, et al

Psychogenic, Non-Epileptic Seizure Screening Aids, Epilepsia; ePub 2017 Sep 12; Kerr, Janio, et al

Must Reads in Epilepsy & Seizures

Psychogenic, Non-Epileptic Seizure Screening Aids, Epilepsia; ePub 2017 Sep 12; Kerr, Janio, et al

FDA Approves Antiepileptic Drug for Age 4 and Older, Sunovion news release; 2017 Sep 14

Survivors of Sepsis Face Long-term Seizure Risk, Neurology; ePub 2017 Sep 6; Reznik, et al

Sudden Deaths Among Patients with Epilepsy, Neurology; ePub 2017 Aug 2; Devinsky, et al

Analysis of Outcomes for Drivers with Epilepsy in MD, Epilepsia; ePub 2017 Jun 1; Ma, Bloch, et al